The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ARENA PHARMACEUTICALS INC | COM NEW | 040047607 | 1,890 | 45,000 | SH | SOLE | 45,000 | 0 | 0 | ||
BIOGEN INC | COM | 09062X103 | 5,695 | 18,000 | SH | SOLE | 18,000 | 0 | 0 | ||
BIOMARIN PHARMACEUTICAL INC | COM | 09061G101 | 8,719 | 103,179 | SH | SOLE | 103,179 | 0 | 0 | ||
BRISTOL-MYERS SQUIBB CO | COM | 110122108 | 9,866 | 176,997 | SH | SOLE | 176,997 | 0 | 0 | ||
CENTENE CORP DEL | COM | 15135B101 | 2,792 | 47,000 | SH | SOLE | 47,000 | 0 | 0 | ||
CIGNA CORP NEW | COM | 125523100 | 9,700 | 54,748 | SH | SOLE | 54,748 | 0 | 0 | ||
CVS HEALTH CORP | COM | 126650100 | 7,713 | 130,000 | SH | SOLE | 130,000 | 0 | 0 | ||
FATE THERAPEUTICS INC | COM | 31189P102 | 3,575 | 160,959 | SH | SOLE | 160,959 | 0 | 0 | ||
MCKESSON CORP | COM | 58155Q103 | 6,898 | 51,000 | SH | SOLE | 51,000 | 0 | 0 | ||
SHOCKWAVE MED INC | COM | 82489T104 | 1,659 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
TANDEM DIABETES CARE INC | COM NEW | 875372203 | 2,747 | 42,685 | SH | SOLE | 42,685 | 0 | 0 | ||
THERMO FISHER SCIENTIFIC INC | COM | 883556102 | 5,359 | 18,896 | SH | SOLE | 18,896 | 0 | 0 | ||
VERTEX PHARMACEUTICALS INC | COM | 92532F100 | 12,481 | 52,453 | SH | SOLE | 52,453 | 0 | 0 | ||
ZOETIS INC | CL A | 98978V103 | 3,545 | 30,125 | SH | SOLE | 30,125 | 0 | 0 |